It was another year of unexpected drug price developments.
In 2020, brand-name drug net prices dropped for the third consecutive year. Meanwhile, brand-name drug list prices grew at their slowest rate in at least 20 years. See our updated analysis below.
I also review the factors behind declining brand-name drug prices. These factors are firmly in place for 2021.
.
Our new Congress may try tackle drug prices in the new year. Let’s hope that their policy perceptions catch up to today’s realities.
Source: Post feed
